Clinical Trial Update: A Brain Imaging Study to Assess the Binding of MSP-2020 to Serotonin 5-HT2A Receptors in Healthy Male Adults [Phase 1]

View source ↗

Summary

Phase 1 brain imaging study to evaluate MSP-2020 binding to serotonin 5-HT2A receptors in healthy male adults; the trial relates to incomplete-response Major De…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• MSP-2020

Snippet

Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc. | Conditions: Incomplete Response - Major Depressive Disorder (IR-MDD) | Phase 1 | Status: RECRUITING